BCMA promotes the survival of long-lived plasma cells and MM cells following interaction with its ligands A Proliferation Inducing Ligand (APRIL) and B-cell Activating Factor (BAFF) (60–63). The gene discussed is TNFSF13B; the disease is Miyoshi myopathy.